Churg-Strauss syndrome in a district hospital

QJM: An International Journal of Medicine

Volumn 91, Issue 3, 1998, Pages 219-229

  Reid, A J C ^a,b   Harrison, B D W ^a   Watts, R A ^a   Watkin, S W ^a   McCann, B G ^a   Scott, D G I ^a  

^a NORFOLK AND NORWICH HOSPITAL   (United Kingdom)

^b HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHOTREXATE;

ADULT; AGED; ARTICLE; ASTHMA; CAUSE OF DEATH; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CLINICAL FEATURE; DISABILITY; DISEASE CLASSIFICATION; EOSINOPHILIA; FEMALE; GENERAL HOSPITAL; HEART; HUMAN; INTESTINE; JOINT; KIDNEY; LUNG; MALE; MORTALITY; MUSCLE; NERVOUS SYSTEM; ONSET AGE; PRIORITY JOURNAL; SKIN; SYSTEMIC VASCULITIS;

EID: 0031905520     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/91.3.219     Document Type: Article

References (43)

1. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984; 63:65-81.
2. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lightfoot Jr RW, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33:1094-100.
3. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951; 27:277-94.
4. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico RA, Rees AJ, van Es LA, Waldherr R, Wiik A. Nomenclature of systemic vasculitidies. Proposal of an international consensus conference. Arthritis Rheum 1994; 37:187-92.
5. Chumbley LC, Harrison EG, De Remee RA. Allergic granulomatosis and angiitis (Churg-Strauss syndrome): report and analysis of 30 cases. Mayo Clin Proc 1977; 52:477-84.
6. Scott DGI, Bacon PA, Elliot PJ, Tribe CR, Wallington TB. Systemic vasculitis in a District General Hospital 1972-1980: clinical and laboratory features, classification and prognosis of 80 cases. Q J Med 1982; 203:292-311.
7. Scott DGI, Watts RA. Classification and epidemiology of systemic vasculitis. Br J Rheumatol 1994; 33:897-900.
8. Watts RA, Carruthers DM, Symmons DPM, Scott DGI. The incidence of rheumatoid vasculitis in the Norwich health authority. Br J Rheumatol 1994; 33:832-33.
9. Carruthers DM, Watts RA, Symmons DPM, Scott DGI. Wegener's granulomatosis - increased incidence or increased recognition? Br J Rheumatol 1996; 35:142-5.
10. Guillevin L, Du Le Thi Huong, Godeau P, Jais P, Wechsler B. Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study in 165 patients. Br J Rheum 1988; 27:258-64.
11. Guillevin L, Jarrousse B, Lok C, Lhote F, Jais JP, Le Thi Huong DU, Bussel A, and the cooperative study group for polyarteritis nodosa. Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids and plasma exchange. A prospective randomized trial of 71 patients. J Rheumatol 1991; 18:567-74.
12. Guillevin L, Fain O, Lhote F, Jarrousse B, Le Thi Huong D, Bussel A, Leon A. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients. Arthritis Rheum 1992; 35:208-15.
13. Guillevin L, Lhote F, Cohen P, Jarrousse B, Lortholary O, Genereau T, Leon A, Bussel A. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients. Arthritis Rheum 1995; 38:1638-45.
14. Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, Thibult N, Casassus P. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine 1996; 75:17-28.
15. Abu-shakra M, Smythe H, Lewtas J, Badley E, Weber D, Keystone E. Outcome of polyarteritis nodosa and Churg-Strauss syndrome. An analysis of twenty-five patients. Arthritis Rheum 1994; 37:1798-803.
16. Kallenberg CGM, Brouwer E, Weening JJ, Cohen Terrvaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994; 46:1-15.
17. Cohen Tervaert JW, Goldschmeding R, Elema JD, Limburg PC, van der Giessen M, Huitema MG, et al. Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum 1990; 33:1264-72.
18. Cohen Tervaert JW, Goldschmeding R, Elema JD, Kr von dem Borne AEG, Kallenberg CGM. Antimyeloperoxidase antibodies in the Churg-Strauss syndrome. Thorax 1991; 46:70-1.
19. Cohen Tervaert JW, Limburg PC, Elema JD, Huitema MG, Horst G, The TH, Kallenberg CG. Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. Am J Med 1991; 91:59-66.
20. Guillevin L, Visser H, Noel LH, Pourrat J, Vernier I, Gayraud M, Oksman F, Lesavre P. Anti-neutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome - 62 patients. J Rheumatol 1993; 13:193-8.
21. Cohen P, Guillevin L, Baril L, Lhote F, Noel LH, Lesavre P. Persistence of antineutrophil cytoplasmic antibodies (ANCA) in asymptomatic patients with systemic polyarteritis nodosa or Churg-Strauss syndrome: follow-up of 53 patients. Clin Exp Rheum 1995; 13:193-8.
22. Watts RA, Carruthers DM, Symmons DPM, Scott DGI. The incidence of rheumatoid vasculitis in the Norwich health authority. Br J Rheumatol 1994; 33:832-3.
23. Zhao MH, Jones SJ, Lockwood CM. Bacterial/permeability-increasing protein (BPI) is an important antigen for antineutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol 1995; 99:49-56.
24. Luqmani RA, Watts RA, Scott DGI, Bacon P. Treatment of vasculitis in rheumatoid arthritis. Ann Med Interne. 1994; 145:566-76.
25. Scott DGI. Classification, epidemiology and treatment of systemic vasculitis. Life Chem Reports 1996:51-64.
26. Haas C, Geneau C, Odinot JM, De Jaeger C, Lavner M, Lowenstein W, Choubrac P, Durand H. L'angeite allerique avec granulomatose: syndrome de Churg et Strauss. Etude retrospective de 16 observations. Ann Med Interne 1991; 142:335-42.
27. Lanham JG. Churg-Strauss syndrome. Br J Hosp Med 1992; 47:667-73.
28. Lipworth BJ, Slater DN, Corrin B, Kesseler ME, Haste AR. Allergic granulomatosis without asthma: a rare 'forme fruste' of the Churg-Strauss syndrome. Resp Med 1989; 83:249-50.
29. Fauci AS, Katz P, Haynes BF, Wolff SM. Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med 1979; 301:235-8.
30. Scott DGI, Bacon PA. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med 1984; 76:377-84.
31. McCune WJ, Golbus J, Zeldes W, Bohlke P, Dunne R, Fox DA. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. N Engl J Med 1988; 318:1423-31.
32. Bacon P. Vasculitis - clinical aspects and therapy. Acta Med Scand 19??; Suppl. 715:157-63.
33. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116:488-98.
34. Hoffman GS. Treatment of Wegener's granulomatosis: time to change the standard of care? Arthritis Rheum 1997; 40:2099-104.
35. Guillevin L, Cordier J-F, Lhote F, Cohen P, Jarrousse B, Royer I, Lesavre P, Jacquot C, Bindi P, Bielefeld P, Desson J-F, Detree F, Dubois A, Hachulla E, Hoen B, Jacomy D, Seigneuric C, Lauque D, Stern M, Longy-Boursier M. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 1997; 40:2187-98.
36. Adu D, Pall A, Luqmani RA, Richards NT, Howie AJ, Emery P, Michael J, Savage COS, Bacon PA. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. Q J Med 1997; 90:401-9.
37. Gayraud M, Le Clercq P, Guillevin L. Treatment of good prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and two cyclophosphamide regimes (daily oral or monthly pulses) in 25 patients. Arthritis Rheum 1994; 37:5352 (abstr).
38. Watt B. Patient; the true story of a rare illness. Viking, 1996.
39. Adu D, Howie AJ, Scott DGI, Bacon PA, McGonigle RJS, Michael J. Polyarteritis and the kidney. Q J Med 1987; 62:221-37.
40. Gordon M, Luqmani RA, Adu D, Greaves I, Richards N, Michael J, Emery P, Howie AJ, Bacon PA. Relapses in patients with a systemic vasculitis. Q J Med 1993; 86:779-89.
41. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery, Savage C, Adu D. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994; 87:671-8.
42. Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage COS, Adu D. Development and initial validation of the vasculitis damage (VDI) for the standardised clinical assessment of damage in the systemic vasculitidies. Arthritis Rheum 1997; 40:371-80.
43. Exley AR, Carruthers DM, Luqmani RA, Kitas GD, Gordon C, Janssen BA, Savage COS, Bacon PA. Damage occurs early in systemic vasculitis and is an index of outcome. Q J Med 1997; 90:391-9.